Upregulated expression of cardiac endothelin-1 participates in myocardial cell growth in Bio14.6 Syrian cardiomyopathic hamsters. 1999

T Inada, and H Fujiwara, and K Hasegawa, and M Araki, and R Yamauchi-Kohno, and H Yabana, and T Fujiwara, and M Tanaka, and S Sasayama
Department of Cardiovascular Medicine, Kyoto University, Graduate School of Medicine, Japan.

OBJECTIVE The purpose of this study is to investigate the role of endogenous endothelin-1 (ET-1) in myocardial growth in Bio 14.6 Syrian cardiomyopathic hamsters (Bio). BACKGROUND While ET-1, as a growth-promoting peptide, has been implicated in the development of secondary cardiac hypertrophy, the role of endogenous ET-1 in cardiac growth in primary myocardial disease is unknown. METHODS We measured left ventricular ET-1 levels by a specific sandwich enzyme-linked immunosorbent assay. Furthermore, we examined the chronic effect of T0201, an ET type A receptor-specific antagonist. RESULTS The ET-1 levels in the left ventricles were 1.8-fold higher (p < 0.0005) at 20 weeks and 6.4-fold higher (p < 0.0001) at 35 weeks in the Bio compared to age-matched control F1B hamsters (F1B). The Bio ET-1 levels in the lungs exhibited an only 1.3-fold elevation at 35 weeks. Immunohistochemistry demonstrated the localization of ET-1 mainly in the cardiac myocytes. The treatment with T0201 significantly reduced the heart weight/body weight ratio in the Bio, but did not affect the heart weight/body weight ratio in the F1B. Histologically, T0201 reduced the myocyte diameter of Bio to a level similar with that of F1B. However, T0201 did not affect the extent of fibrosis in Bio or F1B. CONCLUSIONS The ET-1 level in the heart of cardiomyopathic hamsters increases in stage-dependent and organ-specific manners. Though myocyte degeneration and subsequent replacement fibrosis do not require an ET-1 pathway, the accelerated synthesis of ET-1 in the heart may contribute to the pathological growth of remaining myocytes in this animal model.

UI MeSH Term Description Entries
D008297 Male Males
D008647 Mesocricetus A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research. Hamsters, Golden,Hamsters, Golden Syrian,Hamsters, Syrian,Mesocricetus auratus,Syrian Golden Hamster,Syrian Hamster,Golden Hamster,Golden Hamster, Syrian,Golden Hamsters,Golden Syrian Hamsters,Hamster, Golden,Hamster, Syrian,Hamster, Syrian Golden,Syrian Hamsters
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster

Related Publications

T Inada, and H Fujiwara, and K Hasegawa, and M Araki, and R Yamauchi-Kohno, and H Yabana, and T Fujiwara, and M Tanaka, and S Sasayama
May 1979, Cardiovascular research,
T Inada, and H Fujiwara, and K Hasegawa, and M Araki, and R Yamauchi-Kohno, and H Yabana, and T Fujiwara, and M Tanaka, and S Sasayama
January 1993, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
T Inada, and H Fujiwara, and K Hasegawa, and M Araki, and R Yamauchi-Kohno, and H Yabana, and T Fujiwara, and M Tanaka, and S Sasayama
November 1991, Journal of molecular and cellular cardiology,
T Inada, and H Fujiwara, and K Hasegawa, and M Araki, and R Yamauchi-Kohno, and H Yabana, and T Fujiwara, and M Tanaka, and S Sasayama
January 1992, Journal of andrology,
T Inada, and H Fujiwara, and K Hasegawa, and M Araki, and R Yamauchi-Kohno, and H Yabana, and T Fujiwara, and M Tanaka, and S Sasayama
November 1991, Biochemical and biophysical research communications,
T Inada, and H Fujiwara, and K Hasegawa, and M Araki, and R Yamauchi-Kohno, and H Yabana, and T Fujiwara, and M Tanaka, and S Sasayama
February 1996, Biochemical and biophysical research communications,
T Inada, and H Fujiwara, and K Hasegawa, and M Araki, and R Yamauchi-Kohno, and H Yabana, and T Fujiwara, and M Tanaka, and S Sasayama
March 1992, The Journal of pharmacology and experimental therapeutics,
T Inada, and H Fujiwara, and K Hasegawa, and M Araki, and R Yamauchi-Kohno, and H Yabana, and T Fujiwara, and M Tanaka, and S Sasayama
June 2012, Journal of cardiovascular pharmacology,
T Inada, and H Fujiwara, and K Hasegawa, and M Araki, and R Yamauchi-Kohno, and H Yabana, and T Fujiwara, and M Tanaka, and S Sasayama
March 1998, Cardiology,
T Inada, and H Fujiwara, and K Hasegawa, and M Araki, and R Yamauchi-Kohno, and H Yabana, and T Fujiwara, and M Tanaka, and S Sasayama
January 1993, Journal of cardiovascular pharmacology,
Copied contents to your clipboard!